Large changes in urinary pH caused by the concurrent use of alkalinising drugs such as sodium bicarbonate can, in some patients, have a marked effect on the plasma levels of mexiletine.
The effect does not appear to be predictable. The UK manufacturer of mexiletine recommends that concurrent use should be avoided.
© 2006-2022 Last Updated On: 11/30/2022 (0.01)
Wait 20 seconds...!!!